These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 20188180

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
    Nagarajan S, Ramalingam K, Neelakanta Reddy P, Cereghetti DM, Padma Malar EJ, Rajadas J.
    FEBS J; 2008 May; 275(10):2415-27. PubMed ID: 18422968
    [Abstract] [Full Text] [Related]

  • 3. Probing the amyloid-beta(1-40) fibril environment with substituted tryptophan residues.
    Touchette JC, Williams LL, Ajit D, Gallazzi F, Nichols MR.
    Arch Biochem Biophys; 2010 Feb 15; 494(2):192-7. PubMed ID: 19995549
    [Abstract] [Full Text] [Related]

  • 4. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
    Dong X, Chen W, Mousseau N, Derreumaux P.
    J Chem Phys; 2008 Mar 28; 128(12):125108. PubMed ID: 18376983
    [Abstract] [Full Text] [Related]

  • 5. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
    Shivaprasad S, Wetzel R.
    Biochemistry; 2004 Dec 14; 43(49):15310-7. PubMed ID: 15581343
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD, Condron MM, Teplow DB.
    J Mol Biol; 2001 Oct 05; 312(5):1103-19. PubMed ID: 11580253
    [Abstract] [Full Text] [Related]

  • 7. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J, Siegel SJ, Fu Y, Kelly JW.
    Biochemistry; 2008 Jan 08; 47(1):50-9. PubMed ID: 18078350
    [Abstract] [Full Text] [Related]

  • 8. Molecular dynamics studies of hexamers of amyloid-beta peptide (16-35) and its mutants: influence of charge states on amyloid formation.
    Han W, Wu YD.
    Proteins; 2007 Feb 15; 66(3):575-87. PubMed ID: 17115426
    [Abstract] [Full Text] [Related]

  • 9. Simulation study on the disordered state of an Alzheimer's beta amyloid peptide Abeta(12 36) in water consisting of random-structural, beta-structural, and helical clusters.
    Ikebe J, Kamiya N, Ito J, Shindo H, Higo J.
    Protein Sci; 2007 Aug 15; 16(8):1596-608. PubMed ID: 17656579
    [Abstract] [Full Text] [Related]

  • 10. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO, Tjernberg A, Bark N, Shi Y, Ruzsicska BP, Bu Z, Thyberg J, Callaway DJ.
    Biochem J; 2002 Aug 15; 366(Pt 1):343-51. PubMed ID: 12023906
    [Abstract] [Full Text] [Related]

  • 11. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
    Liu D, Xu Y, Feng Y, Liu H, Shen X, Chen K, Ma J, Jiang H.
    Biochemistry; 2006 Sep 12; 45(36):10963-72. PubMed ID: 16953582
    [Abstract] [Full Text] [Related]

  • 12. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N, Cócera M, Cladera J.
    Biochem Biophys Res Commun; 2007 Oct 05; 361(4):916-21. PubMed ID: 17679138
    [Abstract] [Full Text] [Related]

  • 13. Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities.
    de Groot NS, Aviles FX, Vendrell J, Ventura S.
    FEBS J; 2006 Feb 05; 273(3):658-68. PubMed ID: 16420488
    [Abstract] [Full Text] [Related]

  • 14. Folding landscapes of the Alzheimer amyloid-beta(12-28) peptide.
    Baumketner A, Shea JE.
    J Mol Biol; 2006 Sep 22; 362(3):567-79. PubMed ID: 16930617
    [Abstract] [Full Text] [Related]

  • 15. DHPC strongly affects the structure and oligomerization propensity of Alzheimer's Aβ(1-40) peptide.
    Dahse K, Garvey M, Kovermann M, Vogel A, Balbach J, Fändrich M, Fahr A.
    J Mol Biol; 2010 Nov 05; 403(4):643-59. PubMed ID: 20851128
    [Abstract] [Full Text] [Related]

  • 16. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
    Päiviö A, Jarvet J, Gräslund A, Lannfelt L, Westlind-Danielsson A.
    J Mol Biol; 2004 May 21; 339(1):145-59. PubMed ID: 15123427
    [Abstract] [Full Text] [Related]

  • 17. Observation of multi-step conformation switching in beta-amyloid peptide aggregation by fluorescence resonance energy transfer.
    Kim J, Lee M.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):393-7. PubMed ID: 15020230
    [Abstract] [Full Text] [Related]

  • 18. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL, Sun YX, Jiang ZF.
    FEBS Lett; 2007 Apr 03; 581(7):1269-74. PubMed ID: 17349630
    [Abstract] [Full Text] [Related]

  • 19. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?
    Watson AA, Fairlie DP, Craik DJ.
    Biochemistry; 1998 Sep 15; 37(37):12700-6. PubMed ID: 9737846
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.